Yahoo Search Busca da Web

Entrar

Resultado da Busca

  1. en.wikipedia.org › wiki › Verona_trialVerona trial - Wikipedia

    The Verona Trial (Italian: processo di Verona) was a show trial held in January 1944 in the Italian Social Republic (RSI) to punish the 19 members of the Grand Council of Fascism who had voted for Benito Mussolini's removal from power in the Kingdom of Italy.

  2. ascopubs.org › doi › 10Phase 3 VERONA study of venetoclax with azacitidine to assess ...

    28 de mai. de 2021 · To confirm these benefits, the VERONA study, a randomized, double-blind, phase 3 study (NCT04401748) of patients with treatment-naïve HR-MDS, will assess the safety and efficacy of Ven combined with Aza including CR rate and overall survival.

    • Amer Methqal Zeidan, Jacqueline Suen Garcia, Pierre Fenaux, Uwe Platzbecker, Yasushi Miyazaki, Zhi-J...
    • 2021

  3. Vídeos

    Ver tudo

  4. en.wikipedia.org › wiki › The_Verona_TrialThe Verona Trial - Wikipedia

    The film tells of the final phases of the Italian fascist regime, in particular the affair of the 1944 Verona trial, in which Galeazzo Ciano, Emilio De Bono, Giovanni Marinelli and other eminent Fascist officials (Carlo Pareschi and Luciano Gottardi) were sentenced to death and almost immediately executed by a shooting detachment ...

  5. www.nejm.org › doi › fullAzacitidine and Venetoclax in Previously Untreated Acute ...

    12 de ago. de 2020 · This confirmatory trial (VIALE-A) was designed to evaluate the efficacy and safety of the azacitidine–venetoclax combination regimen as compared with a control regimen of azacitidine and...

  6. Imagens

    • The Verona Trial (1963) - IMDb
    • The Verona Trial (1963) | MUBI
    • Original film title: IL PROCESSO DI VERONA. English title: THE VERONA ...
    • Image gallery for The Verona Trial - FilmAffinity
    • The Verona Trial (1963)

    Ver tudo

  7. www.thelancet.com › journals › lanhaeAzacitidine plus venetoclax in patients with high-risk ...

    2 de set. de 2022 · The ongoing phase 3 VERONA study (NCT04401748) seeks to evaluate whether the addition of venetoclax to azacitidine improves overall survival in patients with high-risk myelodysplastic syndromes.

  8. www.thelancet.com › journals › lanhaeIs there a path forward for immunotherapy in patients with ...

    5 de dez. de 2023 · The remaining accruing phase 3 trials in high-risk myelodysplastic syndromes include the VERONA trial ( NCT04401748) comparing venetoclax in combination with a hypomethylating agent with a hypomethylating agent alone and the SELECT-MDS-1 trial ( NCT04797780) of tamibarotene, an oral selective retinoic acid receptor α agonist, with ...

  9. www.youtube.com › watchPhase III VERONA study of venetoclax with azacitidine in ...

    17 de set. de 2021 · Jacqueline Garcia, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the randomized, double-blind Phase III VERONA study (NCT04401748), a trial-in-progress evaluating venetoclax with...

    • 3 min
    • 150
    • VJHemOnc – Video Journal of Hematological Oncology